中金公司(601995.SH):上半年淨利潤同比預增55%到78%
格隆匯7月14日丨中金公司(601995.SH)公佈2025年半年度業績預吿,預計2025年半年度實現歸屬於母公司股東的淨利潤為人民幣34.53億元到人民幣39.66億元,同比增加55%到78%。扣除非經常性損益事項後,預計2025年半年度實現歸屬於母公司股東的淨利潤為人民幣33.80億元到人民幣38.85億元,同比增加54%到77%。
2025年上半年,資本市場活躍度顯著提升,中國資產持續受到全球資本的關注。公司堅守金融服務實體經濟初心,深耕金融五篇大文章,推動各項業務高質量發展。上半年公司投資銀行、股票業務、財富管理等業務板塊收入同比增加,公司業績同比增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.